LINDA IYAMAH: Open Payments
NPI 1346920485 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,278 in 91 payments from 18 companies in 2025. Trend: 2023 $96 · 2024 $1,709 · 2025 $2,278
Food & beverage: $2,211Education: $67
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 15 | $409 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $406 |
| Neurocrine BioSciences, Inc. | 16 | $312 |
| Axsome Therapeutics, Inc. | 6 | $200 |
| Otsuka America Pharmaceutical, Inc. | 13 | $172 |
| Teva Pharmaceuticals USA, Inc. | 1 | $140 |
| Lundbeck LLC | 6 | $117 |
| Vanda Pharmaceuticals Inc. | 4 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $100 |
| JAZZ PHARMACEUTICALS INC. | 1 | $67 |
Products named: CAPLYTA, INGREZZA, INVEGA SUSTENNA, REXULTI, Auvelity, AUSTEDO XR, SPRAVATO, FANAPT.
Industry payments across TX — which companies pay providers there.
